Fowler Nicole R, Hammers Dustin B, Perkins Anthony J, Summanwar Diana, Higbie Anna, Swartzell Kristen, Brosch Jared R, Willis Deanna R
Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana
Indiana University Center for Aging Research, Indianapolis, Indiana.
Ann Fam Med. 2025 May 27;23(3):191-198. doi: 10.1370/afm.240293.
We assessed the feasibility and acceptability of implementing a digital cognitive assessment (DCA) for Alzheimer disease and related dementias (ADRD) screening into primary care. We also assessed the prevalence of positive screens and measured diagnostic and care outcomes after a positive DCA result.
We conducted a single-arm pragmatic clinical demonstration project in 7 diverse primary care clinics to test implementation of the Linus Health Core Cognitive Evaluation and Digital Clock and Recall DCAs (Linus Health, Inc). Eligible patients were aged ≥65 years. Patients were ineligible if unable to see or hear, not English or Spanish speaking, or if they had a DCA in the past 12 months with an unimpaired or impaired result.
There were 16,708 eligible encounters during the 12-month study period (June 2022-May 2023). A total of 1,808 DCAs (10.8%) were completed by 1,722 unique patients; 3,727 (22.3%) declined, and at 9,232 encounters (55.3%) the physicians declined to have the patient complete the DCA or the encounter was deemed out of scope. Among those who completed DCAs, results for 762 (44.3%) were categorized as unimpaired, 628 (36.5%) borderline, 236 (13.7%) impaired, and 96 (5.6%) inconclusive. Among the 236 patients who were categorized as impaired, 2.1% received a new diagnosis of ADRD, and 5.1% received a new diagnosis of mild cognitive impairment within 90 days after the DCA.
One-half of all patients scored impaired or borderline for cognitive impairment. Digital cognitive assessments can be implemented in primary care, have utility for early detection, and could represent the first step in identification of patients who could benefit from ADRD disease-modifying therapeutics, care management, or other interventions to improve patient and family caregiver outcomes.
我们评估了在初级保健中实施用于阿尔茨海默病及相关痴呆症(ADRD)筛查的数字认知评估(DCA)的可行性和可接受性。我们还评估了阳性筛查的患病率,并在DCA结果呈阳性后测量了诊断和护理结果。
我们在7家不同的初级保健诊所开展了一项单臂实用临床示范项目,以测试Linus Health核心认知评估以及数字时钟与回忆DCA(Linus Health公司)的实施情况。符合条件的患者年龄≥65岁。如果患者无法视物或听力受损、不会说英语或西班牙语,或者在过去12个月内已经进行过DCA且结果正常或异常,则不符合条件。
在为期12个月的研究期间(2022年6月至2023年5月),共有16708次符合条件的就诊。共有1722名不同的患者完成了1808次DCA(10.8%);3727次(22.3%)被拒绝,在9232次就诊(55.3%)中,医生拒绝让患者完成DCA或该就诊被认为超出范围。在完成DCA的患者中,762例(44.3%)结果被分类为正常,628例(36.5%)为临界,236例(13.7%)为异常,96例(5.6%)为不确定。在被分类为异常的236例患者中,2.1%在DCA后90天内被新诊断为ADRD,5.1%被新诊断为轻度认知障碍。
所有患者中有一半的认知障碍评分为异常或临界。数字认知评估可在初级保健中实施,对早期检测有用,并且可能是识别那些可能从ADRD疾病改善疗法、护理管理或其他改善患者及家庭护理人员结局的干预措施中受益的患者的第一步。